M. Kraus & CO Abbott Laboratories Transaction History

M. Kraus & CO

$301 Million
Q4 2024

A detailed history of M. Kraus & CO transactions in Abbott Laboratories stock. As of the latest transaction made, M. Kraus & CO holds 80,826 shares of ABT stock, worth $10.3 Million. This represents 3.04% of its overall portfolio holdings.

Number of Shares

80,826

Previous 81,658 1.02%

Holding current value

$10.3 Million

Previous $9.31 Million 1.79%

% of portfolio

3.04%

Previous 3.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 14, 2025	SELL	$111.93 - $119.39 $93,125 - $99,332	-832 Reduced 1.02%	80,826 $9.14 Million
Q3 2024 Oct 11, 2024	SELL	$100.07 - $118.13 $161,913 - $191,134	-1,618 Reduced 1.94%	81,658 $9.31 Million
Q2 2024 Jul 10, 2024	SELL	$100.73 - $112.44 $200,654 - $223,980	-1,992 Reduced 2.34%	83,276 $8.65 Million
Q1 2024 Apr 10, 2024	BUY	$109.52 - $120.96 $59,688 - $65,923	545 Added 0.64%	85,268 $9.69 Million
Q4 2023 Jan 10, 2024	BUY	$90.19 - $110.4 $16,414 - $20,092	182 Added 0.22%	84,723 $9.33 Million
Q3 2023 Oct 16, 2023	SELL	$95.53 - $114.62 $15,284 - $18,339	-160 Reduced 0.19%	84,541 $8.19 Million
Q2 2023 Jul 14, 2023	BUY	$100.78 - $112.29 $69,235 - $77,143	687 Added 0.82%	84,701 $9.23 Million
Q1 2023 Apr 18, 2023	BUY	$96.86 - $114.01 $75,066 - $88,357	775 Added 0.93%	84,014 $8.51 Million
Q4 2022 Jan 25, 2023	BUY	$95.06 - $111.52 $108,463 - $127,244	1,141 Added 1.39%	83,239 $0
Q3 2022 Oct 27, 2022	BUY	$96.76 - $112.03 $23,609 - $27,335	244 Added 0.3%	82,098 $7.94 Million
Q2 2022 Jul 15, 2022	BUY	$102.07 - $123.37 $21,128 - $25,537	207 Added 0.25%	81,854 $8.89 Million
Q1 2022 Apr 18, 2022	SELL	$114.02 - $139.04 $41,617 - $50,749	-365 Reduced 0.45%	81,647 $9.66 Million
Q4 2021 Jan 19, 2022	SELL	$115.53 - $141.46 $44,132 - $54,037	-382 Reduced 0.46%	82,012 $11.5 Million
Q3 2021 Oct 18, 2021	SELL	$116.66 - $129.06 $76,412 - $84,534	-655 Reduced 0.79%	82,394 $9.73 Million
Q2 2021 Jul 21, 2021	BUY	$105.79 - $124.53 $43,902 - $51,679	415 Added 0.5%	83,049 $9.63 Million
Q1 2021 Apr 19, 2021	BUY	$108.84 - $128.23 $240,427 - $283,260	2,209 Added 2.75%	82,634 $9.9 Million
Q4 2020 Jan 13, 2021	SELL	$105.0 - $114.42 $50,085 - $54,578	-477 Reduced 0.59%	80,425 $8.81 Million
Q3 2020 Oct 09, 2020	SELL	$91.64 - $111.29 $12,829 - $15,580	-140 Reduced 0.17%	80,902 $8.81 Million
Q2 2020 Jul 23, 2020	SELL	$76.57 - $98.0 $90,352 - $115,640	-1,180 Reduced 1.44%	81,042 $7.41 Million
Q1 2020 Apr 14, 2020	SELL	$62.82 - $91.86 $3,141 - $4,593	-50 Reduced 0.06%	82,222 $6.49 Million
Q4 2019 Jan 15, 2020	BUY	$78.51 - $87.4 $87,538 - $97,451	1,115 Added 1.37%	82,272 $7.15 Million
Q3 2019 Oct 10, 2019	BUY	$81.84 - $88.74 $113,021 - $122,549	1,381 Added 1.73%	81,157 $6.79 Million
Q2 2019 Jul 17, 2019	SELL	$72.88 - $85.0 $10,203 - $11,900	-140 Reduced 0.18%	79,776 $6.71 Million
Q1 2019 Apr 15, 2019	SELL	$66.22 - $80.06 $3,973 - $4,803	-60 Reduced 0.08%	79,916 $6.39 Million
Q4 2018 Jan 15, 2019	SELL	$65.56 - $74.27 $6,556 - $7,427	-100 Reduced 0.12%	79,976 $5.79 Million
Q3 2018 Oct 23, 2018	SELL	$60.81 - $73.36 $11,553 - $13,938	-190 Reduced 0.24%	80,076 $5.87 Million
Q2 2018 Jul 11, 2018	SELL	$57.57 - $63.54 $20,437 - $22,556	-355 Reduced 0.44%	80,266 $4.9 Million
Q1 2018 Apr 19, 2018	BUY	$56.27 - $63.62 $70,056 - $79,206	1,245 Added 1.57%	80,621 $4.83 Million
Q4 2017 Jan 18, 2018	BUY	$53.68 - $57.47 $112,191 - $120,112	2,090 Added 2.7%	79,376 $4.53 Million
Q3 2017 Oct 17, 2017	BUY	$48.06 - $53.64 $3.71 Million - $4.15 Million	77,286	77,286 $4.12 Million

Others Institutions Holding ABT

# of Institutions

3,224

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $224B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M. Kraus & CO, based on Form 13F filings with the SEC.

News

Stay updated on M. Kraus & CO with notifications on news.

Account